Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IRON stock hub

Disc Medicine, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IRONis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.6B
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
IRON
In the news

Latest news · IRON

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-35.8
P25 -105.6P50 -46.5P75 -3.1
ROIC-23.5
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IRON market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
180
Groups with data
11
Currency
USD
Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001816736
Company name
Disc Medicine, Inc.
Country
United States
Country code
US
Cusip
254604101
Employees
155
Employees Change
71%
Employees Change Percent
84.52
Enterprise value
$1.9B
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
Isin
US2546041011
Last refreshed
2026-05-10
Market cap
$2.6B
Market cap category
Mid-Cap
Price
$68.26
Price currency
USD
Sector
Healthcare
Sic
2834
Symbol
IRON
Website
https://www.discmedicine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-9.27%
FCF yield
-7.72%
P/B ratio
3.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

9
MetricValue
Net Income
$-241.6M
Net Income Growth Years
0%
Profit Per Employee
$-1.6M
ROA
-22.67
Roa5y
-22.78
ROCE
-36.82
ROE
-35.83
Roe5y
-40.2
ROIC
-23.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

4
MetricValue
Cagr1y
56.79%
Cagr3y
30.61%
EPS Growth Years
0
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Assets
$750.2M
Cash
$730.2M
Current Assets
$747.5M
Current Liabilities
$31.1M
Debt
$31.1M
Debt Equity
$0.05
Equity
$688.4M
Interest Coverage
-74.49
Liabilities
$61.8M
Long Term Assets
$2.8M
Long Term Liabilities
$30.6M
Net Cash
$699.1M
Net Cash By Market Cap
$26.81
Net Cash Growth
5.28%
Net Debt Equity
$-1.02
Tangible Book Value
$688.4M
Tangible Book Value Per Share
$18.03
WACC
15.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
24
Net Working Capital
$-13.4M
Quick ratio
23.45
Working Capital
$716.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-23.05%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
1Y total return
56.74%
200-day SMA
71.9
3Y total return
122.85%
50-day SMA
65.09
50-day SMA vs 200-day SMA
50under200
All Time High
99.5
All Time High Change
-31.4%
All Time High Date
2025-12-08
All Time Low
15
All Time Low Change
355.07%
All Time Low Date
2022-12-30
ATR
2.7
Beta
2.14
Beta1y
1.44
Beta2y
1.69
Ch YTD
-14.04
High
70.3
High52
99.5
High52 Date
2025-12-08
High52ch
-31.4%
Low
67.37
Low52
40
Low52 Date
2026-02-13
Low52ch
70.65%
Ma50ch
4.87%
Premarket Change Percent
1.87
Premarket Price
$68.79
Premarket Volume
5,400
Price vs 200-day SMA
-5.06%
RSI
53.48
RSI Monthly
56.1
RSI Weekly
49.19
Sharpe ratio
1.04x
Sortino ratio
1.67
Total Return
-23.05%
Tr YTD
-14.04
Tr1m
2.11%
Tr1w
2.02%
Tr3m
-14.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

11
MetricValue
Analyst Count
11
Analyst Count Top
7
Analyst Price Target Top
$106
Analyst Ratings
Strong Buy
Analyst Ratings Top
Strong Buy
Earnings EPS Estimate
$-1.69
Earnings Revenue Estimate
50,000x
Operating Income
$-264.7M
Price target
$103
Price Target Change
$51.16
Price Target Change Top
$55.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
33,227,028%
Float Percent
86.98%
Shares Insiders
0.48%
Shares Institutions
98.82%
Shares Out
38,199,089
Shares Qo Q
2.28%
Shares Yo Y
23.05%
Short Float
15.78%
Short Ratio
10.24
Short Shares
13.72

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
$-241.3M
Average Volume
376,737.95x
Bv Per Share
18.03
CAPEX
$-82,000
Ch1m
2.11
Ch1w
2.02
Ch1y
56.74
Ch3m
-14.38
Ch3y
122.9
Ch6m
-18.59
Change
1.08%
Change From Open
0.9
Close
67.53
Days Gap
0.18
Depreciation Amortization
350,000
Dollar Volume
44,799,720.6
Earnings Date
2026-05-05
Earnings Time
bmo
EBIT
$-264.7M
EBITDA
$-264.4M
EPS
$-6.6
F Score
1
FCF
$-201.3M
FCF EV Yield
-10.55x
FCF Per Share
$-5.27
Financing CF
230,853,000
Fiscal Year End
December
Founded
2,017
Income Tax
$293,000
Investing CF
-63,359,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Last Split Type
Never
Last10k Filing Date
2026-02-26
Ma150
75.62
Ma150ch
-9.73%
Ma20
68.62
Ma20ch
-0.52%
Net CF
-33,759,000
Next Earnings Date
2026-08-06
Open
67.65
Optionable
Yes
Position In Range
30.38
Post Close
68.26
Postmarket Change Percent
1.95
Postmarket Price
$69.59
Ppne
2,037,000
Pre Close
67.53
Price Date
2026-05-08
Ptbv Ratio
3.79
Relative Volume
1.74x
Share Based Comp
39,923,000
Tr6m
-18.59%
Us State
Massachusetts
Volume
656,310
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does IRON pay a dividend?

Capital-return profile for this ticker.

Performance

IRON stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+56.7%
S&P 500 1Y: n/a
3Y total return
+122.9%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns IRON?

Insider, institutional, and short-interest positioning.

Institutional ownership
+98.8%
Float: +87.0% of shares outstanding
Insider ownership
+0.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+15.8%
10.2 days to cover
Y/Y dilution
+23.0%
Negative means the company is buying back shares.
Technical

IRON momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
53.5
Neutral momentum band
Price vs 200-day MA
-5.1%
50/200-day relationship not available
Beta (5Y)
2.14
More volatile than the market
Sharpe ratio
1.04
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IRON

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IRON stock rating?

Disc Medicine, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IRON analysis?

The full report lives at /stocks/IRON/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IRON?

The latest report frames IRON around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IRON page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.